Home
Samrat Pharmachem Ltd Quarterly Result

Samrat Pharmachem Ltd
NSE: SAMRATPHARMA
Net Profit - Last Quarter
Samrat Pharmachem Ltd Quarterly Results Key Highlights
- The revenue of Samrat Pharmachem Ltd for the Dec '24 is ₹ 63.67 crore as compare to the Sep '24 revenue of ₹ 70.66 crore.
- This represent the decline of -9.89%a1# The ebitda of Samrat Pharmachem Ltd for the Dec '24 is ₹ 4.18 crore as compare to the Sep '24 ebitda of ₹ 3.85 crore.
- This represent the growth of 8.57%a1# The net profit of Samrat Pharmachem Ltd for the Dec '24 is ₹ 2.78 crore as compare to the Sep '24 net profit of ₹ 2.66 crore.
- This represent the growth of 4.51%a1#.
Samrat Pharmachem Ltd Quarterly Results Analysis
Market Price of Samrat Pharmachem Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 386.1 |
20 Feb 2025 | 379 |
19 Feb 2025 | 364.15 |
18 Feb 2025 | 348 |
17 Feb 2025 | 330.3 |
14 Feb 2025 | 338.55 |
13 Feb 2025 | 350.3 |
12 Feb 2025 | 335.5 |
11 Feb 2025 | 333 |
10 Feb 2025 | 344.8 |
Historical Revenue of Samrat Pharmachem Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Samrat Pharmachem Ltd
Historical EBITDA of Samrat Pharmachem Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Samrat Pharmachem Ltd
Historical Net Profit of Samrat Pharmachem Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Samrat Pharmachem Ltd
Samrat Pharmachem Ltd News Hub
Samrat Pharmachem standalone net profit rises 239.34% in the June 2024 quarter
Net profit of Samrat Pharmachem rose 239.34% to Rs 2.07 crore in the quarter ended June 2024 as agai
Read more
13 Aug 24
Samrat Pharmachem announces board meeting date
Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2024.
Read more
28 Sept 24
Samrat Pharmachem to declare Quarterly Result
Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 February 2025.
Read more
31 Dec 24
Samrat Pharmachem reports standalone net profit of Rs 2.66 crore in the September 2024 quarter
Net profit of Samrat Pharmachem reported to Rs 2.66 crore in the quarter ended September 2024 as aga
Read more
15 Nov 24